SCHEMBL4005596

SCHEMBL4005596

Cc1cc(Nc2nc(S)ncc2Cl)n[nH]1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.59
▸ HTT P42858 1/20 0.59
▸ KMT2A Q03164 1/20 0.59
▸ HSD17B10 Q99714 1/20 0.59
▸ AURKA O14965 9/20 0.55
▸ PAK4 O96013 5/20 0.55
▸ AURKB Q96GD4 5/20 0.55
▸ JAK2 O60674 4/20 0.55
▸ FGFR1 P11362 4/20 0.55
▸ JAK3 P52333 4/20 0.55
▸ PLK4 O00444 4/20 0.55
▸ IGF1R P08069 4/20 0.55
▸ KDR P35968 3/20 0.55
▸ NTRK1 P04629 2/20 0.55
▸ RET P07949 2/20 0.55
▸ FLT3 P36888 2/20 0.55
▸ PTK2 Q05397 2/20 0.55
▸ TNK2 Q07912 2/20 0.55
▸ STK10 O94804 1/20 0.55
▸ FER P16591 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL218642 0.85 MEN1 (0.62) MEN1HTTKMT2AHSD17B10AURKA
SCHEMBL12105461 0.75 AURKA (0.52) MEN1HTTKMT2AHSD17B10AURKA
SCHEMBL14670652 0.74 MEN1 (0.52) MEN1HTTKMT2AHSD17B10AURKA
SCHEMBL218565 0.74 PAK4 (0.60) MEN1HTTKMT2AHSD17B10AURKA
SCHEMBL18853845 0.73 JAK2 (0.84) AURKAPAK4AURKBJAK2FGFR1
Azd-1480 SCHEMBL219103 0.71 JAK2 (1.00) AURKAPAK4AURKBJAK2FGFR1
SCHEMBL2121130 0.71 IGF1R (1.00) AURKAPAK4AURKBJAK2FGFR1
SCHEMBL4038322 0.71 FGFR1 (0.59) MEN1HTTKMT2AHSD17B10AURKA
SCHEMBL4034569 0.71 IGF1R (0.66) AURKAPAK4AURKBJAK2FGFR1
Azd-1480 SCHEMBL3345019 0.71 JAK2 (1.00) AURKAPAK4AURKBJAK2FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009007753-A2 4- (3-AMINOPYRAZOLE) -PYRIMIDINE DERIVATIVEE AND THEIR USE AS TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2009-01-15 — — WO disclosed
Send feedback